Press releases

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its fiscal 2024 fourth quarter and full year...

Franklin Lakes, N.J. and Basel, Switzerland - Oct 08, 2024: BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ten23 health, the human-centric and...

FRANKLIN LAKES, N.J. (October 3, 2024) – BD (Becton, Dickinson and Company), a global leader in medical technology, will highlight its newest innovations in drug delivery systems at CPhI Milan 2024

No admission of liability or wrongdoing; settlement structured to eliminate uncertainty for all stakeholders related to settled cases. Settlement amount within current product litigation reserve...

FRANKLIN LAKES, N.J. (Oct. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Connor Bates has been named worldwide...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and the...

FRANKLIN LAKES, N.J. (September 12, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named to TIME’s 2024...

Study Reports Lower Rate of Central Line Bloodstream Infections, Fewer Occlusions and Cost Savings FRANKLIN LAKES, N.J. (Sept. 6, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a...

Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools Combination of leading monitoring and infusion...